Pacer Advisors’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-69
Closed -$7.69K 3751
2024
Q1
$7.69K Buy
+69
New +$7.69K ﹤0.01% 3567
2021
Q2
Sell
-173
Closed -$70K 1495
2021
Q1
$70K Buy
173
+3
+2% +$1.21K ﹤0.01% 1370
2020
Q4
$113K Buy
170
+118
+227% +$78.4K ﹤0.01% 1348
2020
Q3
$24K Buy
+52
New +$24K ﹤0.01% 1349